Treatment Groups
|
Total \({\bf{NO}}_2^ - \) and \({\bf{NO}}_3^ - \) (pmol/mg/24 hr)
|
p
Value
a
(ANOVA)
|
cGMP (fmol/mg/24 hr)
|
p
Value
‡
(ANOVA)
|
---|
Control
|
29.7 ± 6.5b
|
—
|
5.2 ± 2.8
|
—
|
Injury alone
|
35.4 ± 8.4
|
NSC
|
7.3 ± 3.4
|
NS
|
Injury + MFGlacZ
|
40.1 ± 5.2
|
NS
|
6.8 ± 2.9
|
NS
|
Injury + DFGiNOS
|
121.9 ± 43.1
|
0.001
|
101.3 ± 12.1
|
0.002
|
Injury + DFGiNOS + L-NMA
|
37.4 ± 8.2
|
NS
|
5.6 ± 4.2
|
NS
|
- aVersus uninjured control arterial segments.
- bValues are means ± SD, n - 4, representative of three separate experiments.
- cNS, not significant.